COVID-19 trials registries data warehouse

 Return to trial list

Trial - NCT04344041


Column Value
Trial registration number NCT04344041
Full text link
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

First author
Last imported at : May 3, 2021, 9:44 a.m.
Source : ClinicalTrials.gov

Cédric ANNWEILER

Contact
Last imported at : May 3, 2021, 9:44 a.m.
Source : ClinicalTrials.gov

cedric.annweiler@chu-angers.fr

Registration date
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

2020-04-14

Recruitment status
Last imported at : May 3, 2021, 9:44 a.m.
Source : ClinicalTrials.gov

Completed

Study design
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

RCT

Allocation
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Randomized

Design
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Parallel

Masking
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Open label

Center
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

multi-center

Study aim
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Treatment

Inclusion criteria
Last imported at : May 3, 2021, 9:44 a.m.
Source : ClinicalTrials.gov

inclusion criteria: - age ≥ 65 years old - infection with covid-19 diagnosed with rt-pcr sars-cov-2 or withct-scan of the chest suggesting viral pneumonia of peripheral predominance in a clinically relevant context - patient seen in hospitalization or consultation or in nursing home - diagnosed within the preceding 3 days - having at least one of the following two risk factors for complications: - age ≥75 years - peripheral capillary oxygen saturation (spo2) ≤ 94% ambient air, or a partial oxygen pressure (pao2) to fraction of inspired oxygen (fio2) ratio ≤ 300 mmhg - patients affiliated with or benefitting from a social security scheme - written and signed consent of the patient or a relative or legal representative or, if not possible, emergency inclusion procedure

Exclusion criteria
Last imported at : May 3, 2021, 9:44 a.m.
Source : ClinicalTrials.gov

- organ failure requiring admission to a resuscitation or high dependency unit - comorbidity that is life-threatening in the short-term (life expectancy <3 months) - any reason that makes follow-up at day 28 impossible - vitamin d supplementation in the previous month, with the exception of treatment providing less than 800 iu of vitamin d per day - contraindication for vitamin d supplementation: active granulomatosis (sarcoidosis, tuberculosis, lymphoma), history of calcic lithiasis, known hypervitaminosis d or hypercalcemia, known intolerance to vitamin d - participation in another simultaneous trial - safeguard of justice - peripheral capillary oxygen saturation (spo2) ≤92% in spite of an oxygen therapy > 5l/min

Number of arms
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

2

Funding
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

University Hospital, Angers

Inclusion age min
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

65

Inclusion age max
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

None

Countries
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

France

Type of patients
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Moderate/severe disease at enrollment

Severity scale
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

4: Moderate/severe disease at enrollment

Total sample size
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

260

primary outcome
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Number of death of any cause, during the 14 days following the inclusion and intervention.

Notes
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

None

Phase
Last imported at : Feb. 25, 2021, 7:58 p.m.
Source : ClinicalTrials.gov

Phase 3

Arms
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

[{"arm_notes": "", "treatment_id": 1370, "treatment_name": "Vitamin d", "treatment_type": "Vitamins and dietary supplements", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 1370, "treatment_name": "Vitamin d", "treatment_type": "Vitamins and dietary supplements", "pharmacological_treatment": "Pharmacological treatment"}]